Also known as
mde, eve
Classification
Entactogenpromote emotional openness and connectedness More
Overview
Suggested uses are urethane catalyst, textile softeners, pH control, and epoxy resin curing agents 1.
Medical usage
MDEA currently has no accepted medical uses 2.
What does it look like?
Clear, colourless or yellow liquid without any mechanical impurities 3.
Dosage
How long do its effects last?
Onset of effects
Come up
- oral – 15 – 30 minutes 4.
Peak
- oral – 90 – 120 minutes 4.
Offset
- oral – 1 – 2 hours 4.
Duration of effects
After-effects
- oral – 12 – 48 hours 4.
Pharmacology
MDEA has been shown to act as a releasing agent and reuptake inhibitor of the key monoamine neurotransmitters serotonin, dopamine and noradrenaline 8, which are the neurotransmitters responsible for modulating focus, motivation, pleasure, and reward. This is done by inhibiting the reuptake and reabsorption of monoamine neurotransmitters after they have performed their function of transmitting a neural impulse, allowing them to accumulate in the synaptic cleft and be reused in a manner which causes physically stimulating, sedating, disinhibiting and euphoric effects 9. The often-reported “stoning” effects have been theorised to arise from the higher relative activity MDEA has on releasing serotonin over dopamine compared to MDMASee Ecstasy More.
It has also been noted that MDEA, even at lower doses, stimulates the release of oxytocin and prolactin, two hormones that are currently being studied for their potential roles in modulating the feeling of trust and love 10, 4.
Route of administration
Lethal dosage
Exact toxiccapable of causing injury or death dosage is unknown 4. The oral LD50the amount of a material, given all at once, which causes the death of 50% (one half) of a group of test animals. The LD50 is one way to measure the short-term poisoning potential (acute toxicity) of a material value in the rat is 4.78 g/kg and the dermal LD50the amount of a material, given all at once, which causes the death of 50% (one half) of a group of test animals. The LD50 is one way to measure the short-term poisoning potential (acute toxicity) of a material value in the albino rabbit is 6.24 g/kg 1.
Toxicity
Tolerance
Tolerancethis is the process by which the receptors in your brain become habituated to the action of a drug. When tolerance is reached, more of the drug is required to achieve the same effect. With benzodiazepines, and probably with many other classes of drugs as well, tolerance is virtually always associated with some degree of physical dependence. If you find that you are experiencing tolerance, this is a clear warning sign that you may have formed a dependence. More to many of the effects of MDEA develops with prolonged and repeated use. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about 1 – 1.5 months for the tolerancethis is the process by which the receptors in your brain become habituated to the action of a drug. When tolerance is reached, more of the drug is required to achieve the same effect. With benzodiazepines, and probably with many other classes of drugs as well, tolerance is virtually always associated with some degree of physical dependence. If you find that you are experiencing tolerance, this is a clear warning sign that you may have formed a dependence. More to be reduced to half and 2 – 3 months to be back at baseline (in the absence of further consumption). MDEA presents cross-tolerance with all dopaminergic and serotonergic stimulants and entactogens, meaning that after the consumption of MDEA all of these will have a reduced effect 4.
Effects
Physical effects
- physical euphoriaan intense feeling of pleasure and well-being More,
- pupil dilation,
- spontaneous physical sensations,
- bodily control enhancement,
- perception of bodily heaviness,
- stamina enhancement,
- stimulationcan be defined as any changes in a person's energy levels which are interpreted as stimulating and encouraging when it comes to movement and physical activities such as running, walking, cleaning, socializing, dancing, and climbing More,
- tactile enhancement,
- appetite suppression,
- sedationthe state of being relaxed or sleepy because of a drug More,
- brain zaps,
- dehydration,
- difficulty urinating,
- increased blood pressure,
- increased heart rate,
- increased perspiration,
- teeth grinding,
- temperature regulation suppression,
- temporary erectile dysfunction 4.
Cognitive effects
- anxiety,
- cognitive euphoriastate of intense well-being, happiness, and excitement More,
- compulsive redosing,
- depression,
- irritability,
- mindfulness,
- time distortion,
- creativity enhancement,
- dream potentiationcan be described as a cognitive component which increases the intensity, vividness and frequency of sleeping dream states. This effect also creates higher detail and definition within dreams alongside of an increase in the likelihood of one's dreams becoming lucid. More,
- empathy, affection and sociability enhancement,
- focus enhancement,
- immersion enhancementThis is an effect which can be described as a pronounced increase in one's ability to become fully engulfed within external visual or auditory stimuli such as music, movies, video games and various other forms of media. More,
- increased libido,
- increased music appreciation,
- motivation enhancement,
- stamina enhancement,
- thought acceleration,
- wakefulness,
- anxiety suppression,
- cognitive fatiguethe decline in the ability to think effectively and maintain focus. More,
- disinhibition,
- dream suppression,
- motivation suppression,
- thought deceleration,
- existential self-realisation,
- unity and interconnectedness 4.
Visual effects
- colour enhancement,
- pattern recognition enhancement,
- symmetrical texture repetition,
- tracers,
- double vision,
- vibrating vision,
- peripheral information misinterpretation 4.
Auditory effects
- auditory distortion,
- auditory enhancement,
- auditory hallucinationswhere someone sees, hears, smells, tastes or feels things that don't exist outside of their mind 4.
Overdose
Reported overdose symptoms of MDEA include the following –
- disseminated intravascular coagulationa condition in which blood clots form throughout the body's small blood vessels. These blood clots can reduce or block blood flow through the blood vessels, which can damage the body's organs. More,
- muscle rigidity,
- rhabdomyolysisa condition that may occur when muscle tissue is damaged due to an injury in which muscle in the body is damaged More,
- convulsionswhen your body shakes violently without you meaning it to,
- tachycardiarapid pulse rate,
- hypotensionlow blood pressure More,
- sweating 14.
Risks
Addiction
Can you get addicted?
As with other stimulants, the chronic use of MDEA can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage 4.
Interactions
Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses of each but still increase the potential risk of death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption 4.
- 25x-NBOMe – Both the NBOMe series and this compound induce powerful stimulationcan be defined as any changes in a person's energy levels which are interpreted as stimulating and encouraging when it comes to movement and physical activities such as running, walking, cleaning, socializing, dancing, and climbing More and their interaction may cause severe side-effects. These can include thought loops, seizuresthe outward effect can vary from uncontrolled jerking movement (tonic-clonic seizure) to as subtle as a momentary loss of awareness More, increased blood pressure, vasoconstrictionnarrowing of the blood vessels resulting from contraction of the muscular wall of the vessels (in particular the large arteries and small arterioles), increased heart rate, and heart failure (in extreme cases).
- Alcohol – It is dangerous to combine alcohol, a depressant, with stimulants due to the risk of excessive intoxication. Stimulants decrease the sedativeOne of a diverse group of drugs manufactured for medical purposes to relax the central nervous system. More effect of alcohol which is the main factor most people consider when determining their level of intoxication. Once the stimulanta drug that acts on the Central Nervous System, increasing some rates of function such as heart-rate wears off, the effects of alcohol will be significantly increased, leading to intensified disinhibition as well as respiratory depressionslowing the drive and effectiveness of breathing More. If combined, one should strictly limit themselves to only drinking a certain amount of alcohol per hour.
- DXM – This combination may cause increased heart rate and panic attacks.
- MXE – Increased heart rate and blood pressure may occur.
- Tramadol – This combination can increase the risk of seizuresthe outward effect can vary from uncontrolled jerking movement (tonic-clonic seizure) to as subtle as a momentary loss of awareness More.
- MAOIsMAOIs may be used to treat the symptoms of depression. More – This combination may increase the amount of neurotransmitters such as dopamine to dangerous or even fatal levels. Examples include syrian rue, banisteriopsis caapi, 2C-T-2, 2C-T-7, αMT, and some antidepressants 19.
- Stimulants – The neurotoxic effects of MDEA may be increased when combined with other stimulants.
- Cocaine – This combination may increase strain on the heart 4.
Dangerous
- αMT,
- Tramadol – Tramadol and stimulants both increase the risk of seizuresthe outward effect can vary from uncontrolled jerking movement (tonic-clonic seizure) to as subtle as a momentary loss of awareness More.
- MAOIsMAOIs may be used to treat the symptoms of depression. More – MAO-B inhibitors can increase the potency and duration of phenethylamines unpredictably. MAO-A inhibitors with amphetamine can lead to hypertensive crises 5.
Unsafe
- DOx – The combined stimulating effects of the two can lead to an uncomfortable body-load, while the focusing effects of amphetamine can easily lead to thought loops. Coming down from amphetamines while the DOx is still active can be quite anxiogenicsomething that causes anxiety More.
- NBOMes – Amphetamines and NBOMes both provide considerable stimulationcan be defined as any changes in a person's energy levels which are interpreted as stimulating and encouraging when it comes to movement and physical activities such as running, walking, cleaning, socializing, dancing, and climbing More. When combined they can result in tachycardiarapid pulse rate, hypertensionhigh blood pressure, vasoconstrictionnarrowing of the blood vessels resulting from contraction of the muscular wall of the vessels (in particular the large arteries and small arterioles) and in extreme cases heart failure. The anxiogenicsomething that causes anxiety More and focusing effects of stimulants are also not good in combination with psychedelics as they can lead to unpleasant thought loops. NBOMes are known to cause seizuresthe outward effect can vary from uncontrolled jerking movement (tonic-clonic seizure) to as subtle as a momentary loss of awareness More and stimulants can increase this risk.
- 2C-T-x – Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences. In extreme cases, they can result in severe vasoconstrictionnarrowing of the blood vessels resulting from contraction of the muscular wall of the vessels (in particular the large arteries and small arterioles), tachycardiarapid pulse rate, hypertensionhigh blood pressure, and in extreme cases heart failure.
- 5-MeO-xxT – The anxiogenicsomething that causes anxiety More and focusing effects of stimulants increase the chance of unpleasant thought loops. The combination is generally unnecessary because of the stimulating effects of psychedelics.
- DXM – Both substances raise heart rate, in extreme cases, panic attacks caused by these drugs have led to more serious heart issues.
- PCP – This combination can easily lead to hypermanic states 5.
Footnotes:
Huntsman Corporation, Methyldiethanolamine (MDEA), 2010, http://www.huntsman.com/portal/page/portal/C348531D1F3DA9A2E040EBCD2B6B7B06
3,4-Methylenedioxy-N-ethylamphetamine, 2017, https://en.wikipedia.org/wiki/34-Methylenedioxy-N-ethylamphetamine
Methyldiethanolamine (MDEA), 2017, http://sintez-oka.com/eng/products/alkylethanolamines/mdea/
MDEA, 2017, https://psychonautwiki.org/wiki/MDEA
MDEA, 2017, http://drugs.tripsit.me/mdea
Shulgin, A. and Shulgin, A., Phenethylamines I Have Known And Loved: A Chemical Love Story, 2015, https://www.erowid.org/library/books_online/pihkal/pihkal.shtml
Freudenmann, R. W. and Spitzer, M., The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), CNSthe Central Nervous System, upon which certain drugs act Drug Reviews, 2004, 10, 2, 89-116, https://org.doi/10.1111/j.1527-3458.2004.tb00007.x, http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00007.x/abstractjsessionid=DFEBB1CE08CA49F66D700DD8AF6666FE.f04t03
Fleckenstein, A. E. and Volz, T. J. and Riddle, E. L. and Gibb, J. W. and Hanson, G. R., New Insights into the Mechanism of Action of Amphetamines, Annual Review of Pharmacology and Toxicology, 2007, 47, 681-698, https://doi.org/10.1146/annurev.pharmtox.47.120505.105140, http://www.annualreviews.org/doi/abs/10.1146/annurev.pharmtox.47.120505.105140
Passie, T., Healing with Entactogens: Therapist and Patient Perspectives on MDMA-Assisted Group Psychotherapy, 2012, Multidisciplinary Association for Psychedelic Studies (MAPS), ISBN 0979862272, 92, https://www.amazon.com/Healing-Entactogens-Perspectives-MDMA-Assisted-Psychotherapy/dp/0979862272
Climko, R. P. and Roehrich, H. and Sweeney, D. R. and Al-Razi, J., Ecstasy: A review of MDMASee Ecstasy More and MDA, International Journal of Psychiatry in Medicine, 1986, 16, 4, 359-372, https://www.ncbi.nlm.nih.gov/pubmed/2881902
Kalant, H., The pharmacology and toxicology of “ecstasy” (MDMASee Ecstasy More) and related drugs, Canadian Medical Association Journal, 2001, 165, 7, 917-928, http://www.cmaj.ca/content/165/7/917.full
Freudenmann, R. W. and Spitzer, M., The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), CNSthe Central Nervous System, upon which certain drugs act Drug Reviews, 2004,10, 2, 89-116, http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00007.x/pdf
Tehan, B. and Hardern, R. and Bodenham, A., HyperthermiaThis is a condition in which the body's temperature is higher than normal More associated with 3,4-methylenedioxyethamphetamine (‘Eve’), Anaesthesiathe state in which someone does not feel pain, usually because of drugs they have been given. More, 1993, 48, 6, 507-510, http://dx.doi.org/10.1111/j.1365-2044.1993.tb07072.x
Gouzoulis, E. and Borchardt, D. and Hermle, L., A case of toxiccapable of causing injury or death psychosis induced by ‘eve’ (3,4-methylene-dioxyethyl-amphetamine), Archives of General Psychiatry, 1993, 50, 75
Hermle, L. and Spitzer, M. and Borchardt, D. and Kovar, K. A. and Gouzoulis, E., Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?, Neuropsychopharmacology, 1993, 8, 171-176
Iwersen, S. and Schmoldt, A., Two very different fatal cases associated with the use of methylenedioxyethylamphetamine (MDEA): Eve as deadly as Adam, Journal of Toxicology: Clinical Toxicology, 1996, 34, 241-244
Vaiva, G. and Boss, V. and Bailly, D. and Thomas, P. and Lestavel, P. and Goudemand, M., An “accidental” acute psychosis with ecstasy use, Journal of Psychoactive Drugs, 2001, 33, 1, 95-98, https://doi.org/10.1080/02791072.2001.10400473, https://www.ncbi.nlm.nih.gov/pubmed/11333007
Gillman, P. K., Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicityThis is when too much of something is taken over a short period of time More, British Journal of Anaesthesiathe state in which someone does not feel pain, usually because of drugs they have been given. More, 2005, 95, 4, 434-441, https://doi.org/10.1093/bja/aei210, https://www.ncbi.nlm.nih.gov/pubmed/16051647